Ken Griffin Staar Surgical CO Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$29.97 - $47.42 $1.4 Million - $2.21 Million	46,700 Added 96.09%	95,300 $3.54 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $52.25 $60,912 - $83,600	1,600 Added 3.4%	48,600 $2.31 Million
Q1 2024 May 15, 2024	BUY	$27.67 - $39.61 $727,721 - $1.04 Million	26,300 Added 127.05%	47,000 $1.8 Million
Q4 2023 Feb 14, 2024	SELL	$30.6 - $43.78 $1.01 Million - $1.45 Million	-33,100 Reduced 61.52%	20,700 $646,000
Q3 2023 Nov 14, 2023	BUY	$39.39 - $58.12 $263,913 - $389,404	6,700 Added 14.23%	53,800 $2.16 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $72.82 $514,590 - $742,763	-10,200 Reduced 17.8%	47,100 $2.48 Million
Q1 2023 May 15, 2023	BUY	$51.25 - $79.34 $1.51 Million - $2.33 Million	29,400 Added 105.38%	57,300 $3.66 Million
Q4 2022 Feb 14, 2023	SELL	$46.82 - $76.2 $3 Million - $4.88 Million	-64,100 Reduced 69.67%	27,900 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $3.97 Million - $6.28 Million	56,300 Added 157.7%	92,000 $6.49 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.33B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.